This is a summary of the European public assessment report (EPAR) for Alkindi. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Alkindi. For practical information about using Alkindi, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Replacement therapy of adrenal insufficiency in infants, children and adolescents (from birth to < 18 years old).
Therapeutic Area (MeSH)
ATC Code
H02AB09
ATC Item
hydrocortisone
Pharmacotherapeutic Group
Corticosteroids for systemic use
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| hydrocortisone | N/A | 氢化可的松 |
EMA Name
Alkindi
Medicine Name
Alkindi
Aliases
N/A
